AbbVie files patent for treatment of rheumatoid arthritis with specific pharmaceutical composition

Discover AbbVie Inc.'s innovative patent for an extended-release tablet to treat rheumatoid arthritis. Learn about the specific compound and unique features of this groundbreaking pharmaceutical product.

Mar 13, 2024 - 00:00

Discover AbbVie Inc.'s innovative patent for an extended-release tablet to treat rheumatoid arthritis. Learn about the specific compound and unique features of this groundbreaking pharmaceutical product.

Read the original article

Tags:

Previous Article

Dr. Reddy’s Laboratories files patent for 6-substituted pyridazine compounds for...

Incyte Meets Midphase Skin Condition Trial Goal

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Virpax plans three trials based on platform drug delivery systems in 2024

Virpax plans three trials based on platform drug delive...

Jul 11, 2023

STAT+: Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says

STAT+: Merck CEO refused to testify in Senate because h...

Jan 28, 2024

STAT+: Amputees have better balance, less pain after electrical stimulation, study finds

STAT+: Amputees have better balance, less pain after el...

Dec 15, 2023